IT1273742B - Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose - Google Patents

Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose

Info

Publication number
IT1273742B
IT1273742B ITMI941668A ITMI941668A IT1273742B IT 1273742 B IT1273742 B IT 1273742B IT MI941668 A ITMI941668 A IT MI941668A IT MI941668 A ITMI941668 A IT MI941668A IT 1273742 B IT1273742 B IT 1273742B
Authority
IT
Italy
Prior art keywords
adhesive
treatment
epitals
mucoses
compositions useful
Prior art date
Application number
ITMI941668A
Other languages
English (en)
Inventor
Valle Francesco Della
Silvana Lorenzi
Roberto Cerini
Gabriele Marcolongo
Original Assignee
Lifegroup Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lifegroup Spa filed Critical Lifegroup Spa
Priority to ITMI941668A priority Critical patent/IT1273742B/it
Publication of ITMI941668A0 publication Critical patent/ITMI941668A0/it
Priority to AU32544/95A priority patent/AU3254495A/en
Priority to US08/776,537 priority patent/US5876744A/en
Priority to PCT/EP1995/002999 priority patent/WO1996003973A1/en
Priority to CA002196562A priority patent/CA2196562A1/en
Priority to EP95929025A priority patent/EP0773779A1/en
Publication of ITMI941668A1 publication Critical patent/ITMI941668A1/it
Application granted granted Critical
Publication of IT1273742B publication Critical patent/IT1273742B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/732—Starch; Amylose; Amylopectin; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/733—Alginic acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8129—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Abstract

Composizioni ad elevata bioadesività, mucoadesività e viscoelasticità, contenenti miscele di polimeri sintetici, quali alcol polivinilico e Policarbofil, e di biopolimeri, quali acido alginico, acido ialuronico e dermatansolfato, per il trattamento di stati di secchezza e disidratazione della cute e dei tessuti mucosali e per la veicolazione di principi attivi nell'assorbimento percutaneo.
ITMI941668A 1994-08-01 1994-08-01 Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose IT1273742B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITMI941668A IT1273742B (it) 1994-08-01 1994-08-01 Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose
AU32544/95A AU3254495A (en) 1994-08-01 1995-07-28 Highly bioadhesive and mucoadhesive compositions for the treatmenof epithelia and mucous membranes
US08/776,537 US5876744A (en) 1994-08-01 1995-07-28 Highly bioadhesive and mucoadhesive compositions containing polyvinyl alcohol, polycarbophil and biopolymer for the treatment of skin conditions and as vehicles for active ingredients
PCT/EP1995/002999 WO1996003973A1 (en) 1994-08-01 1995-07-28 Highly bioadhesive and mucoadhesive compositions for the treatmenof epithelia and mucous membranes
CA002196562A CA2196562A1 (en) 1994-08-01 1995-07-28 Highly bioadhesive and mucoadhesive compositions for the treatment of epithelia and mucous membranes
EP95929025A EP0773779A1 (en) 1994-08-01 1995-07-28 Highly bioadhesive and mucoadhesive compositions for the treatmenof epithelia and mucous membranes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI941668A IT1273742B (it) 1994-08-01 1994-08-01 Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose

Publications (3)

Publication Number Publication Date
ITMI941668A0 ITMI941668A0 (it) 1994-08-01
ITMI941668A1 ITMI941668A1 (it) 1996-02-01
IT1273742B true IT1273742B (it) 1997-07-09

Family

ID=11369423

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI941668A IT1273742B (it) 1994-08-01 1994-08-01 Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose

Country Status (6)

Country Link
US (1) US5876744A (it)
EP (1) EP0773779A1 (it)
AU (1) AU3254495A (it)
CA (1) CA2196562A1 (it)
IT (1) IT1273742B (it)
WO (1) WO1996003973A1 (it)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009031006A2 (en) 2007-09-05 2009-03-12 Fidia Farmaceutici S.P.A. Antiviral topical formulations in the form of a bio-adhesive gel

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6596777B1 (en) 1997-05-29 2003-07-22 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes
CZ295983B6 (cs) * 1996-09-27 2005-12-14 Unilever N. V. Kosmetický prostředek a způsob ošetřování pleti
ES2262603T3 (es) 1996-12-13 2006-12-01 Alcon Laboratories, Inc. Composiciones oftalmicas que comprenden aminoalcoholes.
GB2328443B (en) 1997-08-21 2001-09-05 Reckitt & Colmann Prod Ltd In situ formation of pharmaceutically acceptable polymeric material
JP4234803B2 (ja) * 1997-10-27 2009-03-04 久光製薬株式会社 薬物放出速度が制御された医薬組成物
US7799766B2 (en) * 1998-04-08 2010-09-21 Theta Biomedical Consulting & Development Co., Inc. Composition for treating hormonally-dependent cancers
US20050220909A1 (en) * 2004-03-30 2005-10-06 Theoharides Theoharis C Composition for protection against superficial vasodilator flush syndrome
US7906153B2 (en) * 1998-04-08 2011-03-15 Theta Biomedical Consulting & Development Co., Inc. Anti-inflammatory compositions for treating multiple sclerosis
US6984667B2 (en) * 1998-04-08 2006-01-10 Theta Biomedical Consulting And Development Co. Synergistic proteoglycan compositions for inflammatory conditions
US20080153761A1 (en) * 1998-04-08 2008-06-26 Theoharides Theoharis C Compositions for protection against superficial vasodilator flush syndrome, and methods of use
ITFI980104A1 (it) * 1998-05-04 1999-11-04 Hibiscus S R L Composizioni stabilizzate contenenti acido ialuronico,loro preparazione ed uso
AU3327000A (en) * 1999-03-24 2000-10-09 Seikagaku Corporation Artificial saliva
JP2007291117A (ja) * 1999-03-24 2007-11-08 Seikagaku Kogyo Co Ltd 人工唾液
JP4909809B2 (ja) * 1999-03-24 2012-04-04 生化学工業株式会社 人工唾液
JP4804420B2 (ja) * 1999-03-24 2011-11-02 生化学工業株式会社 人工唾液
US20040230559A1 (en) * 1999-08-09 2004-11-18 Mark Newman Information processing device and information processing method
US7141607B1 (en) 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
FR2806302B1 (fr) * 2000-03-16 2002-05-03 Oreal Composition cosmetique ou pharmaceutique sous forme d'un gel aqueux solide, comprenant un alcool polyvinylique et un alcool polyhydrique
FR2806300B1 (fr) * 2000-03-16 2002-05-03 Oreal Composition cosmetique sous forme d'un gel aqueux solide, comprenant un alcool polyvinylique et procede de preparation de cette composition
US6800671B1 (en) * 2000-04-21 2004-10-05 Britesmile, Inc. Low peak exotherm curable compositions
US20020013331A1 (en) 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
FR2811547B1 (fr) * 2000-07-13 2003-09-26 Oreal Composition cosmetique longue tenue comprenant un materiau pro-adhesif particulier
AR031135A1 (es) 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
US6458380B1 (en) * 2000-11-09 2002-10-01 Richard Leaderman Dressing and preparation delivery system
US6635272B2 (en) * 2000-11-09 2003-10-21 Richard N. Leaderman Wound dressing and drug delivery system
US20020172712A1 (en) * 2001-03-19 2002-11-21 Alan Drizen Antiemetic, anti-motion sustained release drug delivery system
US20080182841A1 (en) * 2001-10-29 2008-07-31 Levine Howard L Vaginally administered anti-dysrhythmic agents for treating pelvic pain
US8425892B2 (en) * 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
GB0126064D0 (en) * 2001-10-30 2001-12-19 Reckitt Benckiser Healthcare Improvements in or relating to organic compositions
US6821532B2 (en) 2001-11-16 2004-11-23 Unitel Technologies, Inc. Methods and compositions for the treatment of benign prostatic hypertrophy
WO2003072141A1 (en) * 2002-02-22 2003-09-04 Pharmacia Corporation Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
US20030204180A1 (en) * 2002-04-30 2003-10-30 Kimberly-Clark Worldwide, Inc. Temperature responsive delivery systems
EP1517673A1 (en) * 2002-06-20 2005-03-30 Novartis Consumer Health S.A. Nasal composition comprising a mucopolysaccharide and propylene glycol
ITMI20022271A1 (it) * 2002-10-25 2004-04-26 Farmaka Srl Composizioni farmaceutiche bioadesive a base di anitiinfiammatori non steroidei.
TW200416046A (en) * 2002-12-23 2004-09-01 Alcon Inc Contact lens care compositions containing chitin derivatives
US7238677B2 (en) 2003-03-28 2007-07-03 Kimberly-Clark Worldwide, Inc. Prevention of urogenital infections
US20040209360A1 (en) * 2003-04-18 2004-10-21 Keith Steven C. PVA-based polymer coating for cell culture
FR2863887B1 (fr) * 2003-12-23 2008-05-16 Jean Noel Thorel Procede d'innoformulation d'une base galenique biocompatible
WO2005074883A1 (en) * 2004-01-29 2005-08-18 Sinclair Pharmaceuticals Limited Aqueous compositions containing mixtures of synthetic polymers and biopolymers, useful in the treatment of skin and mucosal tissues dryness, and suitable as vehicles of active ingredients
US7923043B2 (en) 2004-03-30 2011-04-12 Theta Biomedical Consulting & Development Co., Inc. Method for protecting humans against superficial vasodilator flush syndrome
EP1714644B1 (en) 2005-04-19 2012-08-08 Innovet Italia S.r.l. Pharmaceutical compositions for the treatment of chronic ulcerations
US7252834B2 (en) * 2005-04-25 2007-08-07 Clemson University Research Foundation (Curf) Elastin stabilization of connective tissue
CN100341477C (zh) * 2005-09-30 2007-10-10 上海第二医科大学附属第九人民医院 一种防晒、治疗眼部皱纹的膜片
WO2009064806A1 (en) * 2007-11-12 2009-05-22 Endologix, Inc. Method and agent for in-situ stabilization of vascular tissue
WO2009105265A2 (en) * 2008-02-21 2009-08-27 Vatrix Medical, Inc. Treatment of aneurysm with application of connective tissue stabilization agent in combination with a delivery vehicle
US20100016833A1 (en) * 2008-07-15 2010-01-21 Ogle Matthew F Devices for the Treatment of Vascular Aneurysm
US20100119605A1 (en) * 2008-11-12 2010-05-13 Isenburg Jason C Compositions for tissue stabilization
DK2373321T3 (en) * 2008-12-05 2016-06-13 Biomed Device S R L Biovedhæftende platelet lysate and compositions thereof for the treatment of mucostitis
US20100261662A1 (en) * 2009-04-09 2010-10-14 Endologix, Inc. Utilization of mural thrombus for local drug delivery into vascular tissue
US9176146B2 (en) * 2009-08-03 2015-11-03 Theta Biomedical Consulting & Development Co., Inc. Methods of treating autism spectrum disorders and compositions for same
US9050275B2 (en) * 2009-08-03 2015-06-09 Theta Biomedical Consulting & Development Co., Inc. Methods of screening for and treating autism spectrum disorders and compositions for same
US20110218517A1 (en) * 2009-10-09 2011-09-08 Ogle Matthew F In vivo chemical stabilization of vulnerable plaque
US8444624B2 (en) * 2009-10-19 2013-05-21 Vatrix Medical, Inc. Vascular medical devices with sealing elements and procedures for the treatment of isolated vessel sections
HUP0900717A3 (en) * 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
US20110136815A1 (en) * 2009-12-08 2011-06-09 Horst Zerbe Solid oral film dosage forms and methods for making same
CN103260600B (zh) * 2010-12-23 2015-12-02 高露洁-棕榄公司 包含黄原胶、纤维素胶和卡波姆的水性口腔护理组合物
US8911468B2 (en) 2011-01-31 2014-12-16 Vatrix Medical, Inc. Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
JP2014516695A (ja) 2011-05-18 2014-07-17 バトリックス・メディカル・インコーポレイテッド 血管安定化用被覆バルーン
JP2014530855A (ja) * 2011-10-19 2014-11-20 アール．ピー． シェーラーテクノロジーズ エルエルシー 二相式薬剤送達システム
US9283241B2 (en) 2012-07-10 2016-03-15 Clemson University Treatment to render implants resistant to diabetes
WO2014050852A1 (ja) * 2012-09-28 2014-04-03 大正製薬株式会社 粘膜適用軟膏
ES2627868T3 (es) 2012-10-25 2017-07-31 Mdt Int'l S.A. Composiciones mucoadhesivas que comprenden ácido hialurónico y quitosano para aplicación tópica
WO2015142853A1 (en) 2014-03-17 2015-09-24 Encompass Development, Inc. Ocular formulations
JP6334265B2 (ja) * 2014-05-29 2018-05-30 花王株式会社 抗菌性向上物質のスクリーニング方法
ITUB20152932A1 (it) * 2015-08-07 2017-02-07 Laboratori Derivati Organici Spa Composizioni cosmetologiche comprendenti dermatan solfato e condroitin solfato
IT201700009786A1 (it) * 2017-01-30 2018-07-30 For Health Pharma S R L Sostituto lacrimale
IT201800003872A1 (it) * 2018-03-22 2019-09-22 Dtech Soc A Responsabilita Limitata Prodotto per il trattamento terapeutico per la prevenzione e cura di patologie del cavo orale, dei denti e degli impianti dentali
CN114040743A (zh) 2019-06-14 2022-02-11 宝洁公司 免洗型口腔护理组合物
MX2021015131A (es) 2019-06-14 2022-01-24 Procter & Gamble Composiciones para el cuidado bucal para usar y no enjuagar.
MX2021015126A (es) * 2019-06-14 2022-01-24 Procter & Gamble Composiciones para el cuidado bucal para usar y no enjuagar.
WO2020248229A1 (en) * 2019-06-14 2020-12-17 The Procter & Gamble Company Leave-on oral care compositions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59116207A (ja) * 1982-12-22 1984-07-05 Pola Chem Ind Inc メークアップ化粧料の製造方法
WO1985002092A1 (en) * 1983-11-14 1985-05-23 Bio-Mimetics Inc. Bioadhesive compositions and methods of treatment therewith
AU610512B2 (en) * 1986-12-11 1991-05-23 Biomatrix Incorporated Improved hyaluronate-poly (ethylene oxide) mixtures
JPS63212355A (ja) * 1987-02-20 1988-09-05 勝島　明 コンド−ム用保湿潤滑粘膜保護剤
HU203372B (en) * 1989-02-24 1991-07-29 Richter Gedeon Vegyeszet Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
MY105521A (en) * 1989-04-17 1994-10-31 Healthpoint Ltd Moisturizing vehicle for topical application of vitamin a acid.
ES2059300T3 (es) * 1989-10-31 1994-12-01 Columbia Lab Inc Metodo de humidificacion de tejidos y composicion.
US5110605A (en) * 1990-08-21 1992-05-05 Oramed, Inc. Calcium polycarbophil-alginate controlled release composition and method
EP0516026A1 (en) * 1991-05-28 1992-12-02 Takeda Chemical Industries, Ltd. Hydrogel and method of producing same
IT1250421B (it) * 1991-05-30 1995-04-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009031006A2 (en) 2007-09-05 2009-03-12 Fidia Farmaceutici S.P.A. Antiviral topical formulations in the form of a bio-adhesive gel

Also Published As

Publication number Publication date
WO1996003973A1 (en) 1996-02-15
ITMI941668A0 (it) 1994-08-01
ITMI941668A1 (it) 1996-02-01
EP0773779A1 (en) 1997-05-21
CA2196562A1 (en) 1996-02-15
US5876744A (en) 1999-03-02
AU3254495A (en) 1996-03-04

Similar Documents

Publication Publication Date Title
IT1273742B (it) Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose
DE59209658D1 (de) Pharmazeutische zusammensetzung zur wund-, narben- und keloidbehandlung
CA2410706A1 (en) Composition and applicator for topical substance delivery
DE69634430D1 (de) Formulierung fur die wundheilung mit menschlichem plasma fibronektin
CA2203456A1 (en) Topical analgesic composition
MY105521A (en) Moisturizing vehicle for topical application of vitamin a acid.
ATE68960T1 (de) Shampoo-praeparate.
BR9302881A (pt) Composicao oral,processo de promover higiene oral e uso de um agente antibacteriano melhorado na manufactura de uma composicao oral
CA2241188A1 (en) Hydrogel wound dressing and the method of making and using the same
ES2175295T3 (es) Uso de un poliholosido en una composicion destinada a favorecer la descamcion de la piel y su composicion.
ID17016A (id) Turunan-turunan asam yang baru dan penggunaannya sebagai penghambat-penghambat trombin
ZA846196B (en) Gel-like ointment containing indometacin
DE3689117T2 (de) Pharmazeutische Zusammensetzung mit Gehalt an einer Mischung von Kollagen und einem antiseptischen und/oder entzündungshemmenden Wirkstoff und Verfahren zu ihrer Herstellung.
AU674142B2 (en) Use of cosmetic composition
HUP9602498A2 (hu) Antimikrobiális hatású gyógyászati készítmények
DE69913543T8 (de) Dermales Gerüst auf der Grundlage eines neutralisierten Chitosan-Schwammes oder eines neutralisierten gemischten Chitosan-Kollagen-Schwammes
AU1635295A (en) Use of a guar gum in a process for the temporary shaping of keratin fibres
ES2026754A6 (es) Procedimiento de obtencion de una composicion para el tratamiento cosmetico de la piel y del cuerpo.
ATE245443T1 (de) Verfahren zur herstellung von konzentrierten lösungen von fibronectin ohne puffer
SV1996000008A (es) Uso de amidas de acido fenilciclohexilcarboxilicos
PT1115375E (pt) Utilizacao de pelo menos um derivado do acido 10-hidroxi-2-decenoico numa composicao destinada a favorecer a descamacao da pele
FR2787324B1 (fr) Utilisation d'au moins un extrait d'une plante appartenant au genre cecropia et composition cosmetique ou dermopharmaceutique comportant un tel extrait
ES8604017A1 (es) Un procedimiento para la preparacion de una formulacion desodorante de alcohol inferior aminoalcanol inferior o medio.
ES2033927T3 (es) Utilizacion de la forma farmaceutica de "gel" conteniendo acido n-(2,6-cicloro-m-tolil)-antranilico (acido meclofenamico) utilizable en terapia de uso topico.
GEP19971090B (en) Plaster “Fagodermi“

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970828